МOLECULAR DOCKING OF N-SUBSTITUTED DERIVATIVE OF ISOQUINOLONE WITH CATALYC DOMAIN OF PROTEIN KINASE C
- Authors: Gloushko A.A1, Voronkov A.V1, Kodonidi I.P1, Bicherov A.B2, Chernikov M.B1
-
Affiliations:
- Пятигорский медико-фармацевтический институт-филиал ГБОУ ВПО Волг ГМУ Минздрава России, г. Пятигорск
- Научно-исследовательский институт физической и органической химии Южного федерального университета г. Ростов-на-Дону
- Issue: Vol 2, No 1 (2014)
- Pages: 3-7
- Section: Articles
- URL: https://ogarev-online.ru/2307-9266/article/view/111215
- ID: 111215
Cite item
Full Text
Abstract
Endothelium, representing panacrine gland, regulates a whole range of vitally important functions of organism. The disorder of its work - endothelial dysfunction is a key link of development of cardio-vascular diseases. Considering that this group of pathology relates to the most social significant diseases, the correction of endothelial dysfunction and the search of substances with endothelial tread activity, become an actual task for not only the pharmacology but for adjacent interrelated disciplines such as medicinal chemistry. The significant factor in pathogenesis of endothelial dysfunction development is the reduction of activity of endothelial No-synthase enzyme. One of the possible mechanism of reduction of e NOS activity at the pathology is phosphorylation by protein kinase C(PKC). Due to this fact the site of connection of No synthase enzyme by protein kinase is one of perspective method of molecular docking and can be used for search of substances with endothelial-tread activity. The forecast of biological activity of N-substituted derivative of isoquinolone was done with using a molecular docking method. The obtained results give the opportunity to presume the presence of the endothelial-tread activity of this compound.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. A Gloushko
Пятигорский медико-фармацевтический институт-филиал ГБОУ ВПО Волг ГМУ Минздрава России, г. Пятигорск
Email: saha-omega@yandex.ru
A. V Voronkov
Пятигорский медико-фармацевтический институт-филиал ГБОУ ВПО Волг ГМУ Минздрава России, г. Пятигорск
Email: prohor.77@mail.ru
I. P Kodonidi
Пятигорский медико-фармацевтический институт-филиал ГБОУ ВПО Волг ГМУ Минздрава России, г. Пятигорск
Email: kodonidiip@mail.ru
A. B Bicherov
Научно-исследовательский институт физической и органической химии Южного федерального университета г. Ростов-на-Дону
Email: avbicherov@yandex.ru
M. B Chernikov
Пятигорский медико-фармацевтический институт-филиал ГБОУ ВПО Волг ГМУ Минздрава России, г. Пятигорск
Email: pharmax@list.ru
References
- Fleming I., Busse R. Signal transduction of eNOS activation // Cardiovasc. Res. 1999. V. 43. P. 532 - 541.
- Freeley M., Kelleher D., Long A. Regulation of protein kinase C function by phosphorylation on conserved and non-conserved sites // Cell Signal. 2011. V. 23. P. 753 - 762.
- Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Gielis J.F. et al. // Free Radical Biol. Med. 2011. V. 50. P. 765 - 776.
- Kheifets V., Mochly-Rosen D. Insight into intra- and inter-molecular interactions of PKC: Design of specific modulators of kinase function // Pharm. Res. 2007. V. 55. P. 467 - 476.
- Kolluru G.K., Siamwala J.H., Chatterjee S. eNOS phosphorylation in health and disease // Biochimie. 2010. V. 92. P. 1186 - 1198.
- Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function. Morris G. M. et al. // J. Computational Chemistry. 1998. N. 19. P. 1639 - 1662.
- RM1: a Reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I. Rocha G.B. et al. // Journal of Computational Chemistry. 2006. V. 27. P. 1101 - 1111.
- ,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. Van Eis M.J. et al. // Bioorg. Med. Chem. Lett. 2011. V. 21. P. 7367 - 7372.
- Воронков А.В., Глушко А.А. Новая математическая модель для прогнозирования эндотелиопротекторной активности веществ на основе молекулярного докинга // Вопр. биол., мед.и фарм. хим. 2013. Т. 3. С. 42 - 47.
- Эндотелиопротекторы - новый класс фармакологических препаратов. Тюренков И.Н. и соавт. Под ред. Дедова И.И. // Вестн. Рос.акад. мед. наук. 2013. Т. 7. С. 50 - 58.
Supplementary files
